123
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Solid lipid nanoparticle suspension enhanced the therapeutic efficacy of praziquantel against tapeworm

, , , , , & show all
Pages 2367-2374 | Published online: 18 Oct 2011

References

  • DakkakAEchinococcosis/hydatidosis: a severe threat in Mediterranean countriesVet Parasitol20101741–221120888694
  • AnadolDÖzçelikUKiperNGöçmenATreatment of hydatid diseasePaediatr Drugs20013212313511269639
  • RomigTDinkelAMackenstedtUThe present situation of echinococcosis in EuropeParasitol Int200655Suppl 1S18719116352465
  • JenkinsDJEchinococcus granulosus in Australia, widespread and doing well!Parasitol Int200655Suppl 1S20320616352462
  • BattelliGEvaluation of the economic costs of echinococcosisInt Arch Hidatid1997323337
  • CraigPSLarrieuEControl of cystic echinococcosis/hydatidosis: 1863–2002Adv Parasitol20066144350816735171
  • GemmellMALawsonJRRobertsMGControl of echinococcosis/hydatidosis: present status of worldwide progressBull World Health Organ1986643333339
  • CraigPSMcManusDPLightowlersMWPrevention and control of cystic echinococcosisLancet Infect Dis20077638539417521591
  • GemmellMAWorkshop summary: hydatid – new approachesVet Parasitol1994541–32952967846861
  • Urrea-ParísMCasadoNMorenoMRodriguez-CaabeiroFChemoprophylactic praziquantel treatment in experimental hydatidosisParasitol Res200187651051211411955
  • ThomasHGönnertRThe efficacy of praziquantel against cestodes in animalsZ Parasitenk1977522117127906623
  • GemmellMAJohnstonePDOudemansGThe effect of praziquantel on Echinococcus granulosus, Taenia hydatigena and Taenia ovis infections in dogsRes Vet Sci1977231121123905644
  • CaffreyCRChemotherapy of schistosomiasis: present and futureCurr Opin Chem Biol200711443343917652008
  • CioliDPica-MattocciaLPraziquantelParasitol Res200390Suppl 1S3912811543
  • CoboFYarnozCSesmaBAlbendazole plus praziquantel versus albendazole alone as a pre-operative treatment in intra-abdominal hydatisosis caused by Echinococcus granulosusTrop Med Int Health199834624669657508
  • BaleJFJrCysticercosisCurr Treat Options Neurol2000235536011096760
  • LeopoldGUngethümWGrollEDiekmannHWNowakHWegnerDHGClinical pharmacology in normal volunteers of praziquantel, a new drug against schistosomes and cestodes – an example of complex study covering both tolerance and pharmacokineticsEur J Clin Pharmacol197814281291729622
  • JiaoWChengFQunQEpidemiological evaluations of the efficacy of slow-released praziquantel-medicated bars for dogs in the prevention and control of cystic echinococcosis in man and animalsParasitol Int200554423123616231860
  • ChengLLeiLGuoSRIn vitro and in vivo evaluation of praziquantel loaded implants based on PEG/PCL blendsInt J Pharm20103871–212913820005928
  • MouraoSCCostaPISalgadoHRGremiaoMPImprovement of antischistosomal activity of praziquantel by incorporation into phosphatidylcholine- containing liposomesInt J Pharm20052951–215716215848000
  • HrckováGVelebnySCorbaJEffects of free and liposomized praziquantel on the surface morphology and motility of Mesocestoides vogae tetrathyridia (syn. M. corti; Cestoda: Cyclophyllidea) in vitroParasitol Res19988432302389521013
  • YangLGengYLiHZhangYYouJChangYEnhancement the oral bioavailability of praziquantel by incorporation into solid lipid nanoparticlesPharmazie2009642868919320279
  • XieSPanBWangMFormulation, characterization and pharmacokinetics of praziquantel-loaded hydrogenated castor oil solid lipid nanoparticlesNanomedicine20105569370120662641
  • MüllerRHMaderKGohlaWSolid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the artEur J Pharm Biopharm200050116117710840199
  • FreitasCMüllerRHEffect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN™) dispersionsInt J Pharm19981682221229
  • GulnurTMiXYZhangZZUsing antibodies against tegument antigens for copro-ELISA to detect Echinococcus granulous in dogsActa Veterinaria et Zootechnica Sinica2011426845850
  • ZhangWBLiJMcManusDPConcepts in immunology and diagnosis of hydatid diseaseClin Microbiol Rev2003161183612525423
  • DrydenMWPaynPARidleyRSmithVComparison of common fecal flotation techniques for the recovery of parasite eggs and oocystsVet Ther200561152815906267
  • MiróGMateoMMontoyaAVelaECalongeRSurvey of intestinal parasites in stray dogs in the Madrid area and comparison of the efficacy of three anthelmintics in naturally infected dogsParasitol Res2007100231732016915389
  • SlocombeJOHeineJBarutzkiDSlacekBClinical trials of efficacy of praziquantel horse paste 9% against tapeworms and its safety in horsesVet Parasitol20071443–436637017101225
  • DongZXieSYZhuLYWangYWangXFZhouWZPreparation and in vitro, in vivo evaluations of norfloxacin-loaded solid lipid nanopartices for oral deliveryDrug Deliv201118644145021554156
  • PapiniRMatteiniABandinelliPPampuriniFManciantiFEffectiveness of praziquantel for treatment of peritoneal larval cestodiasis in dogs: a case reportVet Parasitol20101701–215816120197213
  • MüllerRHRadtkeMWissingSASolid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparationsAdv Drug Deliver Rev200254Suppl 1S131155
  • SchellingUFrankWWillRRomigTLuciusRChemotherapy with praziquantel has the potential to reduce the prevalence of Echinococcus multilocularis in wild foxes (Vulpes vulpes)Ann Trop Med Parasitol19979121791869307660
  • EckertJDeplazesPBiological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concernClin Microbiol Rev200417110713514726458
  • WangZHWangXMLiuXQEchinococcosis in China, a review of the epidemiology of Echinococcus sppEco Health2008511512618787915
  • AndersenFLConderGAMarslandWPEfficacy of injectable and tablet formulations of praziquantel against mature Echinococcus granulosusAmer J Vet Res1978391118611862736346
  • AndersenFLConderGAMarslandWPEfficacy of injectable and tablet formulations of praziquantel against immature Echinococcus granulosusAmer J Vet Res1979405700701475115